INARI MEDICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI

Lawsuit Overview - Inari Medical and certain executives are charged with failing to disclose material information during the Class Period, violating federal securities laws [3] - The lawsuit is pending in the United States District Court for the Southern District of New York [1] Key Events - On February 29, 2024, Inari Medical disclosed receiving a civil investigative demand from the U.S. Department of Justice related to an investigation under the federal Anti-Kickback Statute and Civil False Claims Act [4] - The investigation primarily concerns meals and consulting service payments provided to healthcare professionals [4] - The company warned that the investigation could have a material impact on its business, results of operations, or financial condition [4] Market Impact - Following the disclosure, Inari Medical's share price fell by over $12 per share, or 21%, from $58.26 to $46.12 on February 29, 2024 [5] - The decline wiped out approximately $700 million in market capitalization in one trading day [5] Legal Action Details - The case is titled Michiana Area Electrical Workers' Pension Fund, IBEW Local 153 v. Inari Medical, Inc., et al, No. 24-cv-03686 [5] - Investors who purchased Inari Medical shares between February 24, 2022, and February 28, 2024, have until July 12, 2024, to file lead plaintiff applications [1]